These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8836412)

  • 1. Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
    Sextro M; Diehl V; Franklin J; Hansmann ML; Anagnostopoulos I; Marafioti T; Stein H
    Ann Oncol; 1996; 7 Suppl 4():61-5. PubMed ID: 8836412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
    Anagnostopoulos I; Hansmann ML; Franssila K; Harris M; Harris NL; Jaffe ES; Han J; van Krieken JM; Poppema S; Marafioti T; Franklin J; Sextro M; Diehl V; Stein H
    Blood; 2000 Sep; 96(5):1889-99. PubMed ID: 10961891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
    von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
    Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
    Grossman DM; Hanson CA; Schnitzer B
    Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte predominant Hodgkin's disease: pathology and clinical implication.
    Franklin J; Tesch H; Hansmann ML; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S39-44. PubMed ID: 9926236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
    Hansmann ML; Stein H; Dallenbach F; Fellbaum C
    Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases.
    Delabie J; Greiner TC; Chan WC; Weisenburger DD
    Am J Surg Pathol; 1996 Mar; 20(3):355-62. PubMed ID: 8772790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
    Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte predominant Hodgkin's disease.
    Ekstrand BC; Horning SJ
    Curr Oncol Rep; 2002 Sep; 4(5):424-33. PubMed ID: 12162918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
    Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
    Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distinction of Hodgkin's disease from B cell lymphoma.
    Warnke RA
    Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases.
    Regula DP; Weiss LM; Warnke RA; Dorfman RF
    Histopathology; 1987 Nov; 11(11):1107-20. PubMed ID: 3692445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
    Pappa VI; Norton AJ; Gupta RK; Wilson AM; Rohatiner AZ; Lister TA
    Ann Oncol; 1995 Jul; 6(6):559-65. PubMed ID: 8573534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).
    Rüdiger T; Jaffe ES; Delsol G; deWolf-Peeters C; Gascoyne RD; Georgii A; Harris NL; Kadin ME; MacLennan KA; Poppema S; Stein H; Weiss LE; Müller-Hermelink HK
    Ann Oncol; 1998; 9 Suppl 5():S31-8. PubMed ID: 9926235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
    Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
    Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
    Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
    Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.